Tyto Care, a Netanya, Israel, and NYC-based telehealth company with technology for conducting comprehensive examinations and telehealth visits, anytime, anywhere, raised $25m in funding.
The round was led by Ping An Global Voyager Fund with participation from Cambia Health Solutions, Walgreens, Orbimed, Fosun Pharma, LionBird and Qure. As part of the round, Tyto Care has the option to expand funding to $28m in the next few months.
In addition, Ping An and Tyto Care will form a strategic partnership to implement Tyto into Ping An’s offerings in the Chinese market.
The company will use the funding to continue its expansion in the US market and enhance its product offerings and smart data analytics, fulfill the demand for its products outside the US and penetrate both the European and Asian markets.
Led by Dedi Gilad, Co-Founder and CEO, Tyto Care connects people to clinicians to provide remote home examination and diagnosis solutions.
The company has three telehealth products:
– TytoHome™ for consumers,
– TytoPro™ for professionals, and
– TytoClinic™ for remote point-of-care locations.
All solutions are designed to replicate a face-to-face clinician visit and include a hand-held modular examination tool for examining the heart, lungs, skin, throat, ears and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms.
The platform also allows for integration with EHR systems and other telehealth platforms.
Following its FDA clearance in late 2016, and the launch of its products in the United States in early 2017, Tyto Care has attracted such clients as major US health systems, telehealth companies, large private practices and employers.